InvestorsHub Logo
Followers 0
Posts 49
Boards Moderated 0
Alias Born 11/14/2019

Re: None

Tuesday, 03/02/2021 3:28:12 PM

Tuesday, March 02, 2021 3:28:12 PM

Post# of 13651
It seems that the FDA may not be doing site inspections during covid. Several large-cap biotechs are unable to get site inspections done. This could explain the delays we are experiencing.

I don't have a crystal ball but I suspect the delays we are seeing may continue for some time. That said I could be wrong and approval could come any week now. I won't be selling any shares still have a strong belief in the product but the timetable is something I have no idea when it will happen.

As much as people hate on management there's nothing else that can be done from their end approval-wise. A substantive update would be nice tho. FDA needs to pull its head out of its arse.



https://www.biocon.com/biocon-biologics-statement-on-the-status-of-bevacizumab-fda-action-date-in-dec-2020/

https://www.benzinga.com/pressreleases/20/11/b18529848/fda-defers-approval-of-daxibotulinumtoxina-for-injection-in-glabellar-lines-due-to-covid-19-relate

https://www.businesswire.com/news/home/20201026005289/en/